Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102617588

  Document Type - Tender Notices

Description - Description: Scope of procurementBrief descriptionThe subject of this publication is the conclusion of contracts pursuant to Section 130a Para. 8 SGB V for several active ingredients as part of a so-called open house procedure: Under the specificatio n of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the conclusion of discount contracts pursuant to Section 130a Para. 8 SGB V for the following active ingredients:Clobetasol (D07AD01)Sodium oxybate (N01AX11, N07XX04)Tafluprost (S01EE05)Telmisartan & Amlodipine (C09DB04)Tree pollen therapeutic allergen (V01AA05)Grass pollen therape

Gt Ref Id - 102617588

Deadline - Feb 01, 2027